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Purpose: To investigate the diagnostic performance of an Artificial Intelligence (AI) system for detection of COVID-
19 in chest radiographs (CXR), and compare results to those of physicians working alone, or with AI support.
Materials and methods: An AI system was fine-tuned to discriminate confirmed COVID-19 pneumonia, from other
viral and bacterial pneumonia and non-pneumonia patients and used to review 302 CXR images from adult pa-
tients retrospectively sourced from nine different databases. Fifty-four physicians blind to diagnosis, were invited
to interpret images under identical conditions in a test set, and randomly assigned either to receive or not receive
support from the AI system. Comparisons were then made between diagnostic performance of physicians working
with and without AI support. AI system performance was evaluated using the area under the receiver operating
characteristic (AUROC), and sensitivity and specificity of physician performance compared to that of the AI
system.
Results: Discrimination by the AI system of COVID-19 pneumonia showed an AUROC curve of 0.96 in the vali-
dation and 0.83 in the external test set, respectively. The AI system outperformed physicians in the AUROC
overall (70% increase in sensitivity and 1% increase in specificity, p< 0.0001). When working with AI support,
physicians increased their diagnostic sensitivity from 47% to 61% (p< 0.001), although specificity decreased
from 79% to 75% (p¼ 0.007).
Conclusions: Our results suggest interpreting chest radiographs (CXR) supported by AI, increases physician
diagnostic sensitivity for COVID-19 detection. This approach involving a human-machine partnership may help
expedite triaging efforts and improve resource allocation in the current crisis.1. Introduction
Starting on December 8, 2019, a series of viral pneumonia cases of
unknown etiology emerged in Wuhan, Hubei province, China [1–3].
Sequencing analysis from respiratory tract samples identified a novel
coronavirus, tentatively named 2019-nCoV by the World Health Orga-
nization and subsequently designated as SARS-CoV-2 by theiptase–polymerase chain reaction
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ccess article under the CC BY-NCInternational Committee on Taxonomy of Viruses [4]. During the first
two months of 2020, the virus causing the disease known as COVID-19
spread worldwide, showing evidence of human-to-human transmission
between close contacts [5]. The World Health Organization declared the
coronavirus outbreak a pandemic on March 11, and countries around the
world struggled with an unprecedented surge in confirmed cases [6].
SARS-CoV-2 causes varying degrees of illness, the most common; CXR, chest radiographs; DL, deep learning; AUROC, area under the receiver







F. Dorr et al. Intelligence-Based Medicine 3-4 (2020) 100014symptoms of which include fever and cough. However, acute respiratory
distress syndrome may develop in a subset of patients, requiring their
admission to intensive care and mechanical ventilation support, some of
whom may die from multiple organ failure [7,8].
Current COVID-19 guidelines rely heavily on clinical, laboratory and
imaging findings to triage patients [9–12]. The World Health Organiza-
tion interim guidance for laboratory testing has recommended use of
nucleic acid amplification tests such as real-time reverse tran-
scriptase–polymerase chain reaction (RT-PCR) for COVID-19 diagnosis in
suspected cases [13]. However, due to overwhelming levels of demand,
RT-PCR kit shortages have been widely reported [14,15]. Also, RT-PCR
from nasopharyngeal and oropharyngeal swabs (the most common res-
piratory tract sampling sites) obtained within the first 14 days of illness
onset, show varying sensitivity rates ranging between 29.6 and 73.3%
and take several hours to process [16].
Although chest radiographs (CXR) and computed tomography (CT)
are key imaging tools for pulmonary disease diagnosis, their role in the
management of COVID-19 has not been clearly defined. Formal state-
ments have been issued by both a multinational consensus from the
Fleischner Society, proposing CXR as surrogate to RT-PCR in resource
constrained environments [12], and by the American College of Radi-
ology which recently recommended avoiding chest CT as a first-line test
for COVID-19 diagnosis, endorsing use of portable CXR instead, in spe-
cific cases [17].
Artificial intelligence (AI) has proven useful for CXR analysis in
numerous clinical settings [18–22], including preliminary work on
COVID-19 [23–26]. However, performance of these algorithms and their
impact on clinical practice has not been thoroughly evaluated. Thus, we
aimed to investigate the diagnostic performance of a fine-tuned AI system
for detection of COVID-19 using DenseNet 121 architecture and compare
results to those of radiologists and emergency care physicians working
with or without AI support.
2. Material and methods
2.1. Dataset construction
For training and validation, a total of 302 CXR images from adult
patients were randomly sourced from nine different databases, eight of
them public and published online, and one from a local institution (pa-
tient age range:17–90 years; gender: 97 female, 156 male, 49 not avail-
able). CXR images collected conformed three distinct groups, those
corresponding to COVID-19 pneumonia (n¼ 102) diagnosis, a second set
of non-COVID-19 pneumonia (n¼ 100) cases, and a third group
including normal CXR images and other non-pneumonia findings
(n¼ 100). For inclusion to the COVID-19 group, prior confirmatory RT-
PCR (retrospective study) was required. The final database was curated
by a radiologist who reviewed every CXR for quality eligibility criteria
(i.e.: adequate exposure and no major artifacts). In cases for which age
data was not available (n¼ 51/302, see appended database) CXR images
were double-checked for complete ossification. An independent test set
including 60 CXR (age range: 20–80 years; gender: 29 female, 25 male, 6
not available), equally distributed among the three groups, was put
together and curated using similar criteria.
2.2. Training and validation of the AI system
We based our COVID-19 CXR detection model on a pre-existing deep
learning (DL) CXR model, previously trained for the CheXpert competi-
tion, and applied in a wide range of pathologies including pneumonia,
pleural effusion, pneumothorax, and cardiomegaly, among others [27].
The model was trained using DenseNet 121 architecture [28], in which
final outputs (i.e., labels) were assigned by the last fully connected layer,
with one neuron for each label resulting in a multi-label prediction. To
perform transfer learning, we replaced the last layer with another fully
connected layer with 3 possible outputs: 1) COVID-19 pneumonia, 2)2
non-COVID-19 pneumonia and, 3) normal CXR or other non-pneumonia
findings. We kept the model loss function (Binary Cross Entropy) and
final activation function (Sigmoid) the same as the original model trained
for CheXpert, being by this means, still a multi-label problem. To train
this new model, parameter weights of every layer were frozen, except for
the last block of layers composed of a dense layer, a dropout layer and the
new output layer, which remained unfrozen for 20 epochs (Fig. 1).
To exploit the limited number of COVID-19 cases, we used the whole
training set and applied to it a 5-fold cross-validation method, splitting
80% of the dataset for training and 20% for internal validation on each
fold.
We calculated the area under the receiver operating characteristic
(AUROC) curves in the three groups for each fold. Once the training was
done for each fold, we selected the epoch that had the best metric average
among all the cross-validation folds (epoch 20) and retrained the algo-
rithm with those best parameters using the whole training set.
The performance of the algorithm was then validated using a
completely independent test set [60]. We evaluated the performance of
the algorithm on this dataset using sensitivity and specificity, as well as
AUROC curve measures. Given that model output was multilabel, we
selected the output class with the highest probability to convert it to a
multiclass problem and calculate the metrics. For example, if the multi-
label sigmoid output prediction was (0.2, 0.6, 0.9) we took the maximum
probability (0.9) and returned the vector (0, 0, 1). We found that by
doing this, instead of retraining the model explicitly with a multi-class
loss and a softmax output, the performance was better and avoided a
bias to label almost everything as COVID positive.
2.3. Clinical performance study design
To evaluate diagnostic performance of physicians interpreting CXRs,
with and without support of the DL-model, we conducted an online
survey. Physicians (radiologists [n¼ 23] and emergency care physicians
[n¼ 31]) had to decide whether CXR findings were compatible with
COVID-19 pneumonia, non-COVID-19 pneumonia or neither. Sixty cases
in total (i.e., the entire test set: 20 COVID-19 pneumonia, 20 non-COVID-
19 pneumonia and 20 non-pneumonia CXRs) were shown to each survey
responder. An AI prediction was shown in randomized fashion to half the
cases in each subset. Physicians had a maximum of 20minutes to com-
plete the survey. A full set of answers is available online.1
2.4. Statistical analysis
To evaluate AI system performance, AUROC was estimated using the
normalized Mann-Whitney U statistic. We then compared sensitivity and
specificity of physicians, to the optimal cutoff point of the AI system. To
establish the effect of AI support on physician performance, we con-
structed a mixed model with a repeated-measures design, including
presence or absence of AI support, seniority level (junior vs senior, based
years since specialty degree, under or over 5 years), type of specialty
(radiologists vs other specialists); with interactions as independent var-
iables and sensitivity and specificity as dependent variables (Supple-
mentary Table). Statistical analyses were conducted using Python scikit-
learn library and Stata version 12.1. Unless noted, mean standard de-
viation is reported. Two-tailed P values< 0.05 were considered statisti-
cally significant.
2.5. Code availability
Because the DL system source code used for this analysis contains
proprietary information, it cannot be made fully available for public
Fig. 1. Convolutional Neural Network Diagram. This chart summarizes the strategy used in the study. Using a convolutional neural network, pre-trained with a
dataset of over 200,000 CXRs and 5 output classes; all layers but the last block of layers were frozen and transferred onto a new network with new labels (COVID-19
pneumonia, Other pneumonias, Normal/Other findings). Final fully-connected layers were then retrained over the transferred ones.
F. Dorr et al. Intelligence-Based Medicine 3-4 (2020) 100014release. However, non-privative code parts have been released in a public
repository that can be found in https://bitbucket.org/aenti/entelai-co
vid-paper. All study experiments and implementation methods are
described in detail and the tool itself is available online at: https:
//covid.entelai.com, to enable independent replication.2.6. Data availability
Local datasets and links to image repositories used in the study are
publicly available online.2
3. Results
3.1. Training and validation of the AI system
We fine-tuned a pre-established AI system using a dataset of 302 CXR
of COVID-19, other pneumonia, and other non-pneumonia cases. After 20
epochs of training, we obtained a mean AUROC curve among the 5 cross-
validation folds of 0.96 0.02 (see Fig. 2 and Table 1).
One of the traditional criticisms of DL models is the risk of "black box"
predictions, implying the information that the model uses to make pre-
dictions is unclear and may not be meaningful. Recently, activation maps
have been developed as a way to depict what the models are using to
support their predictions [29]. We analyzed activation maps for
COVID-19 and compared them to other pneumonias, to validate the
model and identify potential sources of information. The activation maps
were obtained by taking the output of the average pooling layer and
taking the mean across channel dimension [30]. As shown in Fig. 3,
activation maps generated using this AI system relied heavily on lower
pulmonary lobes, and on peripheral lung regions in particular. Of note,
peripheral infection patterns have recently been described as a key
feature in COVID-19 [8,31], suggesting the AI system was able to predict
COVID-19 diagnosis using relevant information from CXRs.2 https://osf.io/6by7h/?view_only&equals;28264f73003245f897a847d3cd4
96ab9.
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Since training can overfit prediction to a particular dataset, we
generated an independent test set comprising 60 images (20 per cate-
gory) to evaluate AI system performance. AUROC, Brier and Mean Ab-
solute Error scores were obtained on a one-vs-rest basis. Brier scores in
particular are widely used in medical research to assess and compare
model prediction accuracy [32]. Values range from 0 to 1, with 0 being
the best possible outcome. Although they can be used as a single multi-
class score, in this study we reported Brier scores by class, to obtain a
better idea of how well the model performed for each one. As shown in
Table 2 and Fig. 4, performance of the model was not as good, but
nevertheless acceptable, since this AI system was able to predict
COVID-19 with a sensitivity and specificity of 80% and an AUROC of
0.84. This difference between the cross-validation and the test results
could be explained by the data sets used. Since the number of instances of
each dataset is low, it is almost impossible to obtain a perfect general-
ization. Themodel could be learning certain particularities of the training
set that, in spite of doing a cross-validation and having regularization by
dropout, the overfitting to the specific dataset could not be completely
overcome. More data will be needed to achieve a similar score between
the cross-validation and the test set.
3.2. Clinical performance results
We next analyzed whether identification and separation of COVID-19
by physicians was adequate, given the novelty of the disease and the lack
of worldwide experience. To this end, we tested the performance of 60
physicians from several different referral centers in South America. Six
physicians were excluded for not completing the survey in time [n¼ 4],
or not answering a minimum number of questions [n¼ 2]). Fifty-four
physicians from Argentina [n¼ 49], Chile [n¼ 4] and Colombia
[n¼ 1] were included. Given the good performance of the model, we
randomly informed physicians what the AI system prediction had been
for 50% of the images (which could be correct or incorrect as per its
performance on the same Test Set). AI system prediction was shared with
physicians as a likelihood percentage for each condition. Physicians
would then have to give the most likely diagnosis, given the AI sugges-
tion. As shown in Fig. 4, sensitivity and specificity for COVID-19
Fig. 2. Performance of the Artificial Intelligence (AI) System in COVID-19 Prediction. Receiver operating characteristic (ROC) curve and area under the curve
(AUC) of the AI system on the validation set for each of the 5 folds, with a mean area under the receiver operating characteristic (AUROC) curve of
0.96 0.02, n¼ 302).
Table 1
Performance of the AI system in the training dataset using the average of 5-fold
cross-validation.
Diagnosis Sensitivity Specificity AUROC
Covid-19 pneumonia (n¼ 102) 94% 81% 0.96
Non-Covid-19 pneumonia (n¼ 100) 55% 95% 0.87
Other (n¼ 100) 84% 91% 0.93
F. Dorr et al. Intelligence-Based Medicine 3-4 (2020) 100014prediction based on CXR by physicians was 47% and 79% respectively,
with an increase in sensitivity to 61% (p< 0.001) and a decrease in
specificity to 74% (p¼ 0.007) when using AI support. No significant
differences between radiologists and emergency care physicians were
observed, nor did years of training affect overall performance results
(data not shown).
4. Discussion
In the setting of the COVID-19 pandemic, it is probable that RT-PCR
tests will become more robust, quicker, and ubiquitous. However, due toFig. 3. Activation Maps of the Artificial Intelligence (AI) System. a) Example o
activation map of Non-COVID-19 pneumonia category. c) Mean activation map of C
Non-COVID-19 pneumonia categories calculated by maxi;jðCovidMeanMapi;j  NonCov
relevant for the differentiation.
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the actual shortage and limitations of RT-PCR kits, diagnostic imaging
modalities such as CXR and CT have been proposed as surrogate methods
for COVID-19 triage. Some researchers have even reported chest CTs as
showing higher sensitivity for COVID-19 detection than RT-PCR from
swab samples [33,34]. Mei et al. went further and used AI to integrate
chest CT findings with clinical symptoms, exposure history and labora-
tory testing achieving an AUROC of 0.92 and had equal sensitivity as
compared to a senior thoracic radiologist [35]. However, the American
College of Radiology currently recommends CT be reserved for hospi-
talized, symptomatic patients with specific clinical indications [17]. CT
also increases exposure to radiation, is less cost-effective, not widely
available and requires appropriate infection control procedures during
and after examination, including closing scanning rooms for up to 1 h for
airborne precautionmeasures [36]. This is why CXR (the most commonly
performed diagnostic imaging examination) has been proposed as
first-line imaging study when COVID-19 is suspected, especially in
resource-constrained scenarios [11,12]. Portable X-ray units are partic-
ularly suitable, as they can be moved to the emergency department (ED)
or intensive care unit and easily cleaned afterwards [17].
Most clinicians have less experience interpreting CXRs thanf a single activation map on a CXR image from the COVID-19 group. b) Mean
OVID-19 pneumonia category. d) Delta activation map between COVID-19 and
idMeanMapi;j, 0) for each pixel (i,j), depicting lower and peripheral areas as more
Table 2
Performance of the AI system in the test dataset.












60% 90% 0.88 0.67 0.14 0.26
Other (n¼ 20) 65% 83% 0.86 0.65 0.15 0.26
AI: artificial intelligence, AUROC: area under the receiver operating character-
istics, MAE: mean absolute error.
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ology training are the ones most often reporting CXR findings. Gatt el al.,
found sensitivity levels as low as 20% for CXR evaluation results by
emergency care physicians [37]. One would expect this sensitivity to be
even lower in the setting of a new disease like COVID-19. At the other end
of the spectrum, Wong et al. found thoracic radiologist sensitivity level
for CXR diagnosis in a cohort of COVID-19 patients was 69% at baseline
[38], and Cozzi et al. found sensitivities as high as 100% in experienced
radiologists [39]. In our study we noted a low sensibility (both in radi-
ologist and emergency care physicians) for the diagnosis of COVID-19
pneumonia. This could be explained by the fact that, at the time of the
clinical study, most physicians that participated in the survey, have been
exposed to few COVID-19 cases. Low sensibility could also be related to
the online survey design, as physicians evaluated CXR in a different
fashion as they do in their clinical practice, with a limited amount of time
to give a diagnosis. We also noted decreased specificity, due to increased
numbers of false positives in the AI-supported group. In every case, false
positives arose from doubts over the “Other Pneumonias” category;
although the AI model correctly predicted and presented the label “Other
Pneumonias”, physicians were still inclined to favor a COVID-19 diag-
nosis. The significance and clinical impact of this effect is unclear and
deserves further evaluation.
AI has proven useful in CXR analysis for many diseases [18–22]. In
the setting of COVID-19 emergence, several AI models based on DL haveFig. 4. Performance of the Artificial Intelligence (AI) System on the Train and
diction. Receiver operating characteristic (ROC) curve and area under the curve (AU
without AI support is compared.
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been developed around the world, with varying results in terms of ac-
curacy detecting COVID-19-infected patients based on CXR [23–26].
Moreover, none of these models have been tested in real or simulated
clinical scenarios.
Murphy et al. developed an AI system for the evaluation of CXR in the
setting of COVID-19 and achieved a lower AUROC (0.81), and their test
set came from a single institution [40]. They compared the performance
of the AI system to radiologist performance but did not evaluate the
change in diagnostic accuracy of radiologist without and with AI support
as we did.
Considering the prevalence of adults in the COVID-19 group, we
chose to exclude pediatric databases to avoid major bias in training and
testing.
Early diagnosis, isolation and prompt clinical management are the
three public health strategies collectively contributing to contain the
spread of COVID-19. AI models building on the first of these premises
might be significant [41]. In this study, we designed and evaluated a DL
model trained to detect COVID-19 on CXR images. On an independent
test dataset, the model showed 80% sensitivity and specificity for
COVID-19 detection with an AUROC value of 0.84. We also observed
improved diagnostic sensitivity in physician performance (both for ra-
diologists and emergency care physicians) and decreased specificity. Of
note, despite AI system support, physicians did not reach or surpass AI
metrics. Our results differ from the work of Patel et al. who tested a
model in a simulated clinical scenario applied to CXR pneumonia diag-
nosis and achieved maximum diagnostic accuracy combining radiologist
and AI performance [42]. This could have been due to lack of formal
training to incorporate AI recommendations, or lack of trust in our model
predictions. Both hypotheses should be further validated in future
studies.
Our model has significant limitations. First, despite the large number
of CXR used to train the original model (around 224,000 images), only a
small number of CXRs were added to our DL model (around 100 images
per category) using a transfer learning approach. Second, our training set
is mostly based on adult patients CXRs from China and Italy. Third, our
model could also be prone to selection bias, as databases ten to include
more severe or complicated cases. Since the disease has emerged
recently, few good quality, curated, COVID-19 CXR databases areTest Sets, Compared to the Performance of Physicians in COVID-19 Pre-
C) of the AI system on the train and test sets. Physician performance with and
F. Dorr et al. Intelligence-Based Medicine 3-4 (2020) 100014available. Inclusion of cases of all ages, from every region around the
world, would certainly improve AI systems diagnostic accuracy and
reliability.
5. Conclusions
In conclusion, our data suggests physician performance can be
improved using AI systems such as the one described here. We showed an
increase in sensitivity from 47% to 61% for COVID-19 prediction based
on CXR. Future prospective studies are needed to further evaluate the
clinical and public health impact of the combined work of physicians and
AI systems.
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